Here's Why CRT Capital Boosted Valeant Pharmaceuticals' Price Target
February 25, 2015 at 11:31 AM EST
In a report published Wednesday, CRT Capital analyst Tim Chiang increased his price target on Buy-rated shares of Valeant ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.